🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An open-label, single institutional phase II trial of losartan in patients ...
Status
Unknown
Location
Oslo University Hospital
Start Date
2019-10-01
Trial ID
NCT03951142
Treatments Being Tested
This multicenter, retrospective observational study aims to identify clinic...
Status
Completed
Location
Ankara Etlik City Hospital
Start Date
2022-11-15
Trial ID
NCT07256184
Treatments Being Tested
This study was conducted to compare survival using pembrolizumab (SCH 90047...
Status
Completed
Location
Multiple Locations
Start Date
2012-11-20
Trial ID
NCT01704287
Treatments Being Tested
The purpose of phase I trial is to determine the safest, most effective dos...
Status
Terminated
Location
Northwestern University
Start Date
2015-09-30
Trial ID
NCT02530502
Treatments Being Tested
In this study, MMRd metastatic colorectal cancer (mCRC) patients who failed...
Status
Completed
Location
Grande Ospedale Metropolitano Niguarda
Start Date
2019-01-23
Trial ID
NCT03519412
Treatments Being Tested
This research study is studying if the investigational drug, Pembrolizumab,...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2024-10-18
Trial ID
NCT06475235
Treatments Being Tested
This clinical trial is a prospective, multicenter, open-label, randomized, ...
Status
Recruiting
Location
Mayo Clinic
Start Date
2025-01-14
Trial ID
NCT06743126
Main Objective of this study is to examine long-term safety of nivolumab mo...
Status
Recruiting
Location
Local Institution - 0220
Start Date
2019-08-09
Trial ID
NCT03899155
This study is a phase II single center exploratory clinical trial aimed at ...
Status
Not Yet Recruiting
Location
inyinhu Cancer Center, UnionMedical College Affiliated Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2025-07-10
Trial ID
NCT07020052
Treatments Being Tested
Glioblastomas (GBM) are the most frequent brain tumors and one of the most ...
Status
Not Yet Recruiting
Location
CHU de Besançon
Start Date
2026-01
Trial ID
NCT07347210
Treatments Being Tested